Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1958227rdf:typepubmed:Citationlld:pubmed
pubmed-article:1958227lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:1958227lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:1958227lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:1958227lifeskim:mentionsumls-concept:C0077149lld:lifeskim
pubmed-article:1958227pubmed:issue11lld:pubmed
pubmed-article:1958227pubmed:dateCreated1991-12-31lld:pubmed
pubmed-article:1958227pubmed:abstractTextAn investigation of the mechanism of action of the antitumour agent trimelamol has established that it is an efficient interstrand DNA cross-linker in vitro, comparable to nitrogen mustards such as melphalan. Studies have shown that the cross-linking reaction is acid-catalysed but, unlike the nitrogen mustards, only partially reversible after treatment with piperidine. The bisalkylation (cross-linking) reaction appears to be concerted, and no "second arm" reaction has been detected. The results of thermal denaturation studies are consistent with general DNA binding, and suggest a preference for GC-rich sites. The acid-catalysed reaction of trimelamol with a model nucleophile (thiophenol) has also been investigated and an adduct resulting from displacement of the three carbinolamine functions has been isolated and characterized.lld:pubmed
pubmed-article:1958227pubmed:languageenglld:pubmed
pubmed-article:1958227pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958227pubmed:citationSubsetIMlld:pubmed
pubmed-article:1958227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958227pubmed:statusMEDLINElld:pubmed
pubmed-article:1958227pubmed:monthNovlld:pubmed
pubmed-article:1958227pubmed:issn0006-2952lld:pubmed
pubmed-article:1958227pubmed:authorpubmed-author:JacksonCClld:pubmed
pubmed-article:1958227pubmed:authorpubmed-author:ThurstonD EDElld:pubmed
pubmed-article:1958227pubmed:authorpubmed-author:SaundersRRlld:pubmed
pubmed-article:1958227pubmed:authorpubmed-author:GodfreyRRlld:pubmed
pubmed-article:1958227pubmed:authorpubmed-author:JenkinsT CTClld:pubmed
pubmed-article:1958227pubmed:authorpubmed-author:HartleyJ AJAlld:pubmed
pubmed-article:1958227pubmed:issnTypePrintlld:pubmed
pubmed-article:1958227pubmed:day6lld:pubmed
pubmed-article:1958227pubmed:volume42lld:pubmed
pubmed-article:1958227pubmed:ownerNLMlld:pubmed
pubmed-article:1958227pubmed:authorsCompleteYlld:pubmed
pubmed-article:1958227pubmed:pagination2091-7lld:pubmed
pubmed-article:1958227pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:1958227pubmed:meshHeadingpubmed-meshheading:1958227-...lld:pubmed
pubmed-article:1958227pubmed:meshHeadingpubmed-meshheading:1958227-...lld:pubmed
pubmed-article:1958227pubmed:meshHeadingpubmed-meshheading:1958227-...lld:pubmed
pubmed-article:1958227pubmed:meshHeadingpubmed-meshheading:1958227-...lld:pubmed
pubmed-article:1958227pubmed:meshHeadingpubmed-meshheading:1958227-...lld:pubmed
pubmed-article:1958227pubmed:meshHeadingpubmed-meshheading:1958227-...lld:pubmed
pubmed-article:1958227pubmed:meshHeadingpubmed-meshheading:1958227-...lld:pubmed
pubmed-article:1958227pubmed:meshHeadingpubmed-meshheading:1958227-...lld:pubmed
pubmed-article:1958227pubmed:year1991lld:pubmed
pubmed-article:1958227pubmed:articleTitleN2,N4,N6-tri(hydroxymethyl)-N2,N4,N6-trimethylmelamine (trimelamol) is an efficient DNA cross-linking agent in vitro.lld:pubmed
pubmed-article:1958227pubmed:affiliationSchool of Pharmacy and Biomedical Sciences, Portsmouth Polytechnic, Hants.lld:pubmed
pubmed-article:1958227pubmed:publicationTypeJournal Articlelld:pubmed